145 related articles for article (PubMed ID: 36938792)
1. Development of medicines for rare diseases and inborn errors of metabolism: Toward novel public-private partnerships.
Rosenberg N; Stolwijk NN; van den Berg S; Heus JJ; van der Wel V; van Gelder T; Bosch AM; de Visser SJ; Hollak CEM
J Inherit Metab Dis; 2023 Sep; 46(5):806-816. PubMed ID: 36938792
[TBL] [Abstract][Full Text] [Related]
2. Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development.
Davis AM; Engkvist O; Fairclough RJ; Feierberg I; Freeman A; Iyer P
SLAS Discov; 2021 Jun; 26(5):604-619. PubMed ID: 33586501
[TBL] [Abstract][Full Text] [Related]
3. Public-private partnership (PPP) development: Toward building a PPP framework for healthy eating.
De Pinho Campos K; Cohen JE; Gastaldo D; Jadad AR
Int J Health Plann Manage; 2019 Jan; 34(1):e142-e156. PubMed ID: 30488981
[TBL] [Abstract][Full Text] [Related]
4. Typological analysis of public-private partnerships in the veterinary domain.
Galière M; Peyre M; Muñoz F; Poupaud M; Dehove A; Roger F; Dieuzy-Labaye I
PLoS One; 2019; 14(10):e0224079. PubMed ID: 31671123
[TBL] [Abstract][Full Text] [Related]
5. Principles for building public-private partnerships to benefit food safety, nutrition, and health research.
Rowe S; Alexander N; Kretser A; Steele R; Kretsch M; Applebaum R; Clydesdale F; Cummins D; Hentges E; Navia J; Jarvis A; Falci K
Nutr Rev; 2013 Oct; 71(10):682-91. PubMed ID: 24117791
[TBL] [Abstract][Full Text] [Related]
6. Promoting population health with public-private partnerships: Where's the evidence?
Parker LA; Zaragoza GA; Hernández-Aguado I
BMC Public Health; 2019 Nov; 19(1):1438. PubMed ID: 31675935
[TBL] [Abstract][Full Text] [Related]
7. Public-Private Partnerships and Undernutrition: Examples and Future Prospects.
Hoddinott J; Gillespie S; Yosef S
World Rev Nutr Diet; 2016; 115():233-8. PubMed ID: 27198661
[TBL] [Abstract][Full Text] [Related]
8. Challenges to Establish Effective Public-Private Partnerships to Address Malnutrition in All Its Forms.
Fanzo J; Shawar YR; Shyam T; Das S; Shiffman J
Int J Health Policy Manag; 2021 Dec; 10(12):934-945. PubMed ID: 33619927
[TBL] [Abstract][Full Text] [Related]
9. Role of public-private partnerships in achieving UNAIDS HIV treatment targets.
Shrivastava R; Fonjungo PN; Kebede Y; Bhimaraj R; Zavahir S; Mwangi C; Gadde R; Alexander H; Riley PL; Kim A; Nkengasong JN
BMC Health Serv Res; 2019 Jan; 19(1):46. PubMed ID: 30658625
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.
de Vrueh RLA; Crommelin DJA
Pharm Res; 2017 Oct; 34(10):1985-1999. PubMed ID: 28589444
[TBL] [Abstract][Full Text] [Related]
12. An evaluation tool to strengthen the collaborative process of the public-private partnership in the veterinary domain.
Poupaud M; Antoine-Moussiaux N; Dieuzy-Labaye I; Peyre M
PLoS One; 2021; 16(5):e0252103. PubMed ID: 34048436
[TBL] [Abstract][Full Text] [Related]
13. A zebra or a painted horse? Are hospital PPPs infrastructure partnerships with stripes or a separate species?
Montagu D; Harding A
World Hosp Health Serv; 2012; 48(2):15-9. PubMed ID: 22913125
[TBL] [Abstract][Full Text] [Related]
14. DDIEM: drug database for inborn errors of metabolism.
Abdelhakim M; McMurray E; Syed AR; Kafkas S; Kamau AA; Schofield PN; Hoehndorf R
Orphanet J Rare Dis; 2020 Jun; 15(1):146. PubMed ID: 32527280
[TBL] [Abstract][Full Text] [Related]
15. Role of Academic Biobanks in Public-Private Partnerships in the European Biobanking and BioMolecular Resources Research Infrastructure Community.
Hämäläinen I; Törnwall O; Simell B; Zatloukal K; Perola M; van Ommen GB
Biopreserv Biobank; 2019; 17(1):46-51. PubMed ID: 30499696
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of inborn errors of metabolism illustrating challenges in orphan diseases.
Das AM
J Pharmacol Toxicol Methods; 2016; 81():9-14. PubMed ID: 26921514
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions.
Shapiro E; Bernstein J; Adams HR; Barbier AJ; Buracchio T; Como P; Delaney KA; Eichler F; Goldsmith JC; Hogan M; Kovacs S; Mink JW; Odenkirchen J; Parisi MA; Skrinar A; Waisbren SE; Mulberg AE
Mol Genet Metab; 2016 Jun; 118(2):65-9. PubMed ID: 27132782
[TBL] [Abstract][Full Text] [Related]
18. The public-private partnerships in healthcare sector in China.
Liu B; Shi L; Min H; Liang H; Dong J
Chronic Dis Transl Med; 2023 Dec; 9(4):288-298. PubMed ID: 37915390
[TBL] [Abstract][Full Text] [Related]
19. Support of public-private partnerships in health promotion and conflicts of interest.
Hernandez-Aguado I; Zaragoza GA
BMJ Open; 2016 Apr; 6(4):e009342. PubMed ID: 27091816
[TBL] [Abstract][Full Text] [Related]
20. Public-Private Partnerships in the health sector: the Danish experience.
Vrangbaek K
Health Econ Policy Law; 2008 Apr; 3(Pt 2):141-63. PubMed ID: 18634625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
